Steve Schonfeld’s Entera Bio ENTX Stock Holding History

Steve Schonfeld’s Portfolio ENTX Stock Details ENTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$104K	Buy	58,871 +3,648	+7%	+$4.56K	﹤0.01%	2303
2026 Q1	$61.3K	Sell	55,223 -541,362	-91%	-$760K	﹤0.01%	1944
2025 Q4	$1.16M	Buy	596,585 +29,629	+5%	+$69.5K	0.01%	1075
2025 Q3	$1.09M	Sell	566,956 -37,566	-6%	-$71.9K	0.01%	1321
2025 Q2	$1.15M	Buy	604,522 +5,366	+0.9%	+$10.6K	0.01%	1242
2025 Q1	$1.02M	Sell	599,156 -33,155	-5%	-$72.1K	0.01%	1282
2024 Q4	$1.34M	Sell	632,311 -16,289	-3%	-$30.4K	0.01%	996
2024 Q3	$1.23M	Sell	648,600 -23,158	-3%	-$41.1K	0.01%	1091
2024 Q2	$1.24M	Buy	+671,758	New	+$1.47M	0.01%	1112

Other funds holding ENTX

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

SFCM

Seven Fleet Capital Management Mountain View, California $606M AUM

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Steve Schonfeld's ENTX Position: Q2 2026 in Review

Steve Schonfeld increased its Entera Bio (ENTX) stake by 6.6% in Q2 2026, buying an estimated $4.56K and bringing the position to 58,871 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #2303.

Steve Schonfeld first reported a position in ENTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.34M in Q4 2024. 27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

Steve Schonfeld held 58,871 shares of Entera Bio worth $104K as of Q2 2026.
Steve Schonfeld bought 3,648 Entera Bio shares in Q2 2026, an estimated $4.56K.
Entera Bio made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2303 holding.
Steve Schonfeld first reported a position in Entera Bio in Q2 2024 and has held it in 9 quarters since.
Steve Schonfeld's Entera Bio position peaked at $1.34M in Q4 2024.
27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.